[Hub]/) : Traits : Heel bone mineral density (BMD) T-score, automated (left) :

chr2:53,647,729-55,895,321

Best TWAS P=7.72e-39 · Best GWAS P=7.63e-55 conditioned to NaN

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 CommonMind Brain Pre-frontal Cortex EML6 0.06 0.00 blup 675 0.03 9.2e-05 -8.7 -9.2 4.3e-20 0.00 0.58 0.01 TRUE
2 GTEx Artery Aorta AC093110.3 0.13 0.14 lasso 8 0.10 4.5e-06 7.4 7.7 2.0e-14 0.03 0.99 0.00 FALSE
3 GTEx Artery Tibial AC093110.3 0.11 0.14 lasso 3 0.14 2.5e-11 7.4 7.5 8.8e-14 0.03 1.00 0.00 FALSE
4 GTEx Breast Mammary Tissue (Female) AC093110.3 0.11 0.00 lasso 3 0.00 2.2e-01 6.8 7.9 2.8e-15 0.08 0.06 0.05 FALSE
5 GTEx Cells Transformed fibroblasts AC093110.3 0.21 0.13 lasso 6 0.11 1.3e-08 -8.9 9.0 1.7e-19 -0.03 1.00 0.00 TRUE
6 GTEx Pancreas EML6 0.34 0.11 lasso 10 0.13 3.9e-06 7.0 -5.8 7.1e-09 0.00 0.94 0.00 FALSE
7 GTEx Thyroid EML6 0.26 0.20 enet 46 0.24 5.8e-18 6.6 -5.8 5.2e-09 0.09 1.00 0.00 FALSE
8 GTEx Whole Blood SPTBN1 0.13 0.04 lasso 6 0.08 5.7e-08 -5.9 -8.5 1.6e-17 -0.13 0.99 0.00 TRUE
9 METSIM Adipose EML6 0.05 0.06 lasso 3 0.05 1.5e-08 5.5 5.7 1.1e-08 0.00 1.00 0.00 FALSE
10 NTR Blood ACYP2 0.02 0.02 enet 15 0.02 8.9e-07 1.6 5.6 2.4e-08 0.32 1.00 0.00 TRUE
11 NTR Blood SPTBN1 0.06 0.04 bslmm 640 0.04 3.2e-14 -10.0 -12.6 1.4e-36 -0.14 1.00 0.00 TRUE
12 ROSMAP Brain Pre-frontal Cortex SPTBN1 0.10 0.03 enet 22 0.06 1.1e-08 3.0 -5.4 6.7e-08 -0.15 0.86 0.00 TRUE
13 ROSMAP Brain Pre-frontal Cortex TSPYL6 0.07 0.03 lasso 2 0.05 6.5e-07 -4.6 5.4 6.5e-08 0.12 0.96 0.00 TRUE
14 ROSMAP Brain Pre-frontal Cortex AC092839.1 0.10 0.07 enet 17 0.09 4.3e-12 -8.5 -7.7 1.0e-14 0.01 1.00 0.00 FALSE
15 The Cancer Genome Atlas Breast Invasive Carcinoma RPL23AP32 0.02 0.02 blup 50 0.02 1.1e-05 -9.5 -10.0 1.5e-23 -0.03 0.02 0.98 FALSE
16 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma C2orf73 0.09 0.01 lasso 3 0.06 2.0e-07 2.6 -5.3 1.1e-07 0.00 0.46 0.02 FALSE
17 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma EML6 0.14 0.13 lasso 4 0.13 1.0e-14 -8.2 -7.7 1.2e-14 -0.01 0.40 0.60 TRUE
18 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma RPL23AP32 0.09 0.10 lasso 4 0.10 7.3e-11 5.5 -7.8 4.8e-15 -0.01 0.73 0.27 TRUE
19 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma C2orf73 0.16 0.05 enet 12 0.06 2.4e-04 -4.5 -6.8 9.3e-12 -0.24 0.48 0.09 FALSE
20 The Cancer Genome Atlas Brain Lower Grade Glioma C2orf73 0.19 0.08 lasso 6 0.16 2.8e-18 -4.4 -5.5 2.8e-08 -0.09 1.00 0.00 TRUE
21 The Cancer Genome Atlas Brain Lower Grade Glioma RPL23AP32 0.05 0.03 blup 50 0.04 4.3e-05 -8.8 -10.1 8.0e-24 -0.03 0.06 0.94 FALSE
22 The Cancer Genome Atlas Brain Lower Grade Glioma SPTBN1 0.10 0.04 lasso 3 0.05 2.1e-06 -8.1 -7.4 1.6e-13 -0.23 0.84 0.00 FALSE
23 The Cancer Genome Atlas Prostate Adenocarcinoma RPL23AP32 0.06 0.02 enet 6 0.03 1.7e-04 -8.4 -7.0 2.5e-12 0.02 0.06 0.79 FALSE
24 The Cancer Genome Atlas Soft Tissue Sarcoma RPL23AP32 0.04 0.03 blup 50 0.02 1.2e-02 -8.8 -9.9 4.0e-23 -0.02 0.01 0.85 TRUE
25 The Cancer Genome Atlas Thyroid Carcinoma EML6 0.05 0.05 lasso 4 0.05 3.1e-05 5.5 -6.2 4.1e-10 0.03 0.86 0.03 TRUE
26 The Cancer Genome Atlas Thyroid Carcinoma RPL23AP32 0.06 0.04 blup 50 0.03 1.3e-03 -8.5 -9.4 3.7e-21 -0.01 0.04 0.86 FALSE
27 The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma SPTBN1 0.39 0.04 blup 163 0.12 3.6e-04 -11.9 -13.0 7.7e-39 -0.49 0.04 0.47 TRUE